SCHEMBL3430716

SCHEMBL3430716

C=Cc1cc2ccccc2nc1-c1cccc(OC)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.50
PDE10A Q9Y233 4/20 0.48
MAPT P10636 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
ALDH1A1 P00352 4/20 0.46
LMNA P02545 3/20 0.46
KMT2A Q03164 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46
MEN1 O00255 2/20 0.46
POLB P06746 2/20 0.46
HPGD P15428 2/20 0.46
RXFP1 Q9HBX9 1/20 0.46
CYP1A2 P05177 3/20 0.45
CYP3A4 P08684 3/20 0.45
CYP2C9 P11712 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL985339 0.81 PDE10A (0.56) PDE10AMAPTTDP1RAB9ASMN1; SMN2
SCHEMBL30462969 0.79 ADORA2A (0.53) ADORA2APDE10AMAPTTDP1RAB9A
SCHEMBL3430717 0.78 MAPT (0.46) ADORA2APDE10AMAPTTDP1RAB9A
SCHEMBL7690919 0.78 L3MBTL1 (0.61) ADORA2APDE10AMAPTTDP1RAB9A
SCHEMBL30486858 0.77 ADORA2A (0.54) ADORA2APDE10AMAPTTDP1RAB9A
SCHEMBL29207046 0.77 ADORA2A (0.54) ADORA2APDE10AMAPTTDP1RAB9A
SCHEMBL29207037 0.76 KDM4E (0.50) ADORA2APDE10AMAPTTDP1RAB9A
SCHEMBL28815572 0.74 ADORA2A (0.61) ADORA2APDE10AMAPTTDP1RAB9A
SCHEMBL895785 0.73 ALDH1A1 (0.49) MAPTTDP1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL28280657 0.72 ADORA2A (0.52) ADORA2APDE10AMAPTTDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2147913-A1 Styrylquinolines, their process of preparation and their therapeutic uses BioAlliance Pharma (FR) 2010-01-27 EP claimed
EP-2147913-A1 Styrylquinolines, their process of preparation and their therapeutic uses BioAlliance Pharma (FR) 2010-01-27 EP disclosed